FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

34552411000001107: Meijumet 500mg modified-release tablets (Medreich Plc) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 21-Jun 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
104548301000001110 Meijumet 500mg modified-release tablets (Medreich Plc) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
104548401000001119 Meijumet 500mg modified-release tablets (Medreich Plc) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Meijumet 500mg modified-release tablets (Medreich Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Meijumet 500mg modified-release tablets (Medreich Plc) Is a Metformin 500mg modified-release tablets true Inferred relationship Existential restriction modifier
Meijumet 500mg modified-release tablets (Medreich Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Meijumet 500mg modified-release tablets (Medreich Plc) Is a Metformin hydrochloride 500mg m/r tablet false Inferred relationship Existential restriction modifier
Meijumet 500mg modified-release tablets (Medreich Plc) Has active ingredient Metformin hydrochloride true Inferred relationship Existential restriction modifier
Meijumet 500mg modified-release tablets (Medreich Plc) Has manufactured dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Meijumet 500mg modified-release tablets (Medreich Plc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Meijumet 500mg modified-release tablets (Medreich Plc) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Meijumet 500mg modified-release tablets (Medreich Plc) Has specific active ingredient Metformin hydrochloride true Inferred relationship Existential restriction modifier
Meijumet 500mg modified-release tablets (Medreich Plc) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Meijumet 500mg modified-release tablets (Medreich Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Meijumet 500mg modified-release tablets (Medreich Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Meijumet 500mg modified-release tablets (Medreich Plc) Is a Meijumet true Inferred relationship Existential restriction modifier
Meijumet 500mg modified-release tablets (Medreich Plc) Is a Metformin 500mg modified-release tablets false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Meijumet 500mg modified-release tablets (Medreich Plc) 28 tablet 2 x 14 tablets Has AMP True Meijumet 500mg modified-release tablets (Medreich Plc) Inferred relationship Existential restriction modifier
Meijumet 500mg modified-release tablets (Medreich Plc) 56 tablet 4 x 14 tablets Has AMP True Meijumet 500mg modified-release tablets (Medreich Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start